 |
The Journal of Neuroscience, May 24, 2006, 26(21):5777-5785; doi:10.1523/JNEUROSCI.5223-05.2006
Previous Article | Next Article 
Behavioral/Systems/Cognitive
Pronociceptive and Antinociceptive Effects of Estradiol through Endogenous Opioid Neurotransmission in Women
Yolanda R. Smith,1,2
Christian S. Stohler,6
Thomas E. Nichols,3
Joshua A. Bueller,4
Robert A. Koeppe,5 and
Jon-Kar Zubieta4,5
1Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology, 2Womens Health Program, 3Department of Biostatistics, 4Department of Psychiatry and Molecular and Behavioral Neuroscience Institute, and 5Department of Radiology, University of Michigan, Ann Arbor, Michigan 48109, and 6Dental School, University of Maryland, Baltimore, Maryland, 21201
Correspondence should be addressed to Dr. Jon-Kar Zubieta, University of Michigan, Molecular and Behavioral Neuroscience Institute, 205 Zina Pitcher Place, Ann Arbor, MI 48109-0720. Email: zubieta{at}umich.edu
Prominent interindividual and sex-dependent differences have been described in responses to sustained pain and other stressful stimuli. Variations in µ-opioid receptor-mediated endogenous opioid neurotransmission may underlie some of these processes. We examined both baseline µ-opioid receptor levels and the activation of this neurotransmitter system during sustained pain using positron emission tomography in a sample of young healthy men and women. Women were studied twice, during low and high estrogen states. The high-estrogen state was associated with regional increases in baseline µ-opioid receptor availability in vivo and a greater activation of endogenous opioid neurotransmission during the pain stressor. The latter did not differ from that obtained in males. During the low estrogen condition, however, significant reductions in endogenous opioid tone were observed at the level of thalamus, nucleus accumbens, and amygdala, which were associated with hyperalgesic responses. Estrogen-associated variations in the activity of µ-opioid neurotransmission correlated with individual ratings of the sensory and affective perceptions of the pain and the subsequent recall of that experience. These data demonstrate a significant role of estrogen in modulating endogenous opioid neurotransmission and associated psychophysical responses to a pain stressor in humans.
Key words: µ-opioid receptors; pain; stress; sex differences; PET; human
Received Dec. 7, 2005;
revised March 23, 2006;
accepted April 13, 2006.
Correspondence should be addressed to Dr. Jon-Kar Zubieta, University of Michigan, Molecular and Behavioral Neuroscience Institute, 205 Zina Pitcher Place, Ann Arbor, MI 48109-0720. Email: zubieta{at}umich.edu
Related articles in J. Neurosci.:
- This Week in The Journal
J. Neurosci. 2006 26: i.
[Full Text]
This article has been cited by other articles:

|
 |

|
 |
 
T. M. Love, C. S. Stohler, and J.-K. Zubieta
Positron Emission Tomography Measures of Endogenous Opioid Neurotransmission and Impulsiveness Traits in Humans
Arch Gen Psychiatry,
October 1, 2009;
66(10):
1124 - 1134.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. R. Reed, H. K. Chadha, and C. H. Hubscher
Effects of 17{beta}-Estradiol on Responses of Viscerosomatic Convergent Thalamic Neurons in the Ovariectomized Female Rat
J Neurophysiol,
August 1, 2009;
102(2):
1062 - 1074.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. R. Kramer and L. L. Bellinger
The Effects of Cycling Levels of 17{beta}-Estradiol and Progesterone on the Magnitude of Temporomandibular Joint-Induced Nociception
Endocrinology,
August 1, 2009;
150(8):
3680 - 3689.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. W. Hurley and M. C. B. Adams
Sex, Gender, and Pain: An Overview of a Complex Field
Anesth. Analg.,
July 1, 2008;
107(1):
309 - 317.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Henriksen and F. Willoch
Imaging of opioid receptors in the central nervous system
Brain,
May 1, 2008;
131(5):
1171 - 1196.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Scott, C. S. Stohler, C. M. Egnatuk, H. Wang, R. A. Koeppe, and J.-K. Zubieta
Placebo and Nocebo Effects Are Defined by Opposite Opioid and Dopaminergic Responses
Arch Gen Psychiatry,
February 1, 2008;
65(2):
220 - 231.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Perspectives on Neuroscience and Behavior
Neuroscientist,
December 1, 2006;
12(6):
461 - 462.
[PDF]
|
 |
|

|
 |

|
 |
 
S. E. Kennedy, R. A. Koeppe, E. A. Young, and J.-K. Zubieta
Dysregulation of endogenous opioid emotion regulation circuitry in major depression in women.
Arch Gen Psychiatry,
November 1, 2006;
63(11):
1199 - 1208.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|